The healthcare services provider post third-quarter adjusted earnings of $7.15 a share, beating analysts’ estimates of $7.

Medical costs continue to surge more than expected for health insurers.

UnitedHealth's stock was diving 3.7%, to pull back from a record high, and enough to pace the Dow's premarket losers, after the healthcare giant's earnings report disappointed investors. UnitedHealth's stock is the highest priced Dow component,

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. Find out why UNH stock is a Buy.

UnitedHealth Group delivered a profit beat for the quarter, but not the kind that investors wanted to see. Heard on the Street columnist David Wainer explains how medical costs, which have become some

There was little in the way of economic data to move the needle, so market participants focused on an earnings calendar featuring several blue chip stocks. Goldman Sachs (GS, -0.04%), for one, handily beat top- and bottom-line expectations for its third quarter,